Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study.

camptocormia dropped head syndrome inflammatory myopathies myositis

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
18 Jul 2023
Historique:
received: 15 12 2022
revised: 10 06 2023
accepted: 27 06 2023
medline: 18 7 2023
pubmed: 18 7 2023
entrez: 18 7 2023
Statut: aheadofprint

Résumé

Inaugural axial muscle involvement, defined as dropped head syndrome (DHS) and/or camptocormia (CC), is poorly described in inflammatory myopathies (IM). This study aimed to further characterize IM patients with inaugural DHS/CC, their outcome and care management. This retrospective study included IM patients diagnosed between 2000 and 2021. The main inclusion criterion was IM revealed by axial muscle deficit (DHS/CC). Twenty-seven patients were included; median (IQR) age at first symptoms was 66.0 years (55.5-75.0); 21 were female (77.8%). There were 9 inclusion-body myositis (IBM, 33.3%), 9 overlap myositis (OM, 33.3%), 5 dermatomyositis (DM, 18.5%), 2 immune checkpoint inhibitor-related myositis (7.4%), 1 focal myositis (3.7%) and 1 myositis with anti-Hu antibodies (3.7%). Age at first symptoms was ≤ 70 years in 16 patients (59.3%), including all DM patients and 8/9 OM patients (88.9%). In this group, partial remission of the disease was obtained in 9/16 (56.3%) and complete remission in 1/16 patient (6.3%); regression of DHS/CC was achieved in 3/16 patients (18.8%). Conversely, in the group of 11 patients aged > 70 years at first symptoms, there were 8 IBM (72.7%). Partial remission was obtained in 5/11 patients (45.5%), the disease was stable in 6/11 patients (54.5%); no complete remission was obtained nor regression of DHS/CC. The analysis of IM patients with inaugural DHS/CC delineates 2 groups of patients according to the age at first symptoms in terms of clinical and outcome specificities, and proposes an adapted diagnostic and care management approach to prevent long-term complications.

Identifiants

pubmed: 37462538
pii: 7225849
doi: 10.1093/rheumatology/kead347
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Auteurs

Marie Robert (M)

Service de Médecine Interne et immunologie clinique, Centre Hospitalier Universitaire Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

Lola E R Lessard (LER)

Service d'Electroneuromyographie et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.
Laboratoire Physiopathologie et Génétique du Neurone et du Muscle (PGNM), CNRS UMR5261-INSERM U1315, Institut NeuroMyoGène-Université Claude Bernard Lyon 1, Lyon, France.

Françoise Bouhour (F)

Service d'Electroneuromyographie et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.

Philippe Petiot (P)

Service d'Electroneuromyographie et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.

Tanguy Fenouil (T)

Service de Cytologie et d'Anatomie Pathologique, Département de Neuropathologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.
Equipe Ribosome Traduction et Cancer, UMR Inserm 1052 CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

Juliette Svahn (J)

Service d'Electroneuromyographie et Pathologies Neuromusculaires, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.

Julie Fiscus (J)

Service d'Immunologie, UF Autoimmunité, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

Nicole Fabien (N)

Service d'Immunologie, UF Autoimmunité, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

Laurent Pérard (L)

Service de Médecine Interne, Centre Hospitalier Saint Joseph Saint Luc, Lyon, France.

Philip Robinson (P)

Direction de la Recherche en Santé, Hospices Civils de Lyon, Lyon, France.

Isabelle Durieu (I)

Service de Médecine interne, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

Fabienne Coury (F)

Département de Rhumatologie, Hôpital Lyon Sud, Hospices civils de Lyon, Pierre-Bénite, France.
Inserm UMR1033, Université Claude Bernard Lyon 1, Lyon, France.

Nathalie Streichenberger (N)

Laboratoire Physiopathologie et Génétique du Neurone et du Muscle (PGNM), CNRS UMR5261-INSERM U1315, Institut NeuroMyoGène-Université Claude Bernard Lyon 1, Lyon, France.
Service de Cytologie et d'Anatomie Pathologique, Département de Neuropathologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France.

Arnaud Hot (A)

Service de Médecine Interne et immunologie clinique, Centre Hospitalier Universitaire Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

Laure Gallay (L)

Service de Médecine Interne et immunologie clinique, Centre Hospitalier Universitaire Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
Laboratoire Cell therapy & musculoskeletal disorders, Université de Genève, Dr T Laumonier, 1 Rue Michel Servet, Genève 4, CH-1211.

Classifications MeSH